Do urocortins have a role in treating cardiovascular disease?

Drug Discovery Today
Ekaterini ChatzakiStavroula Baritaki

Abstract

Corticotropin-releasing factor (CRF) and the three homolog neuropeptides, urocortin (UCN) 1, 2 and 3, are the major neuroendocrine factors implicated in the response of the body to stress. Recent evidence suggests that UCNs have a significant role in the pathogenesis and management of cardiovascular disease, such as congestive heart failure, ischemic heart disease, and hypertension. These data led to the initiation of clinical trials testing a possible role of UCNs in the diagnosis and therapy of cardiovascular disease, with encouraging results. Here, we summarize the available literature concerning the role of UCNs in the cardiovascular system, focusing on the emerging data creating a potential for clinical applications.

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Biochemical and Biophysical Research Communications
Cui YangShengnan Li
Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
Joseph V MoxonJonathan Golledge
The Veterinary Journal
Gemma Fraga VelosoPauline M Jamieson
© 2022 Meta ULC. All rights reserved